What is your approach to adjuvant RT or chemoRT in LS-SCLC s/p lobectomy with N1 disease?
What factors prompt you to offer adjuvant RT? What would be included in your field? Is elective mediastinal RT still used? Assume initial imaging was negative for nodes and surgical mediastinal evaluation was negative.
2 Answers
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on
I am unaware of any data suggesting a benefit of adjuvant RT in this scenario assuming completely resected. In the absence of data, I would not recommend adjuvant RT in an N1 patient, rationale below. Adjuvant systemic therapy would be strongly recommended.
My thought process to this is that SCLC ha...
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC
Answered on
This was thought to be an early-stage disease (T1-T2N0M0) and the decision was made to undergo lobectomy + hilar/mediastinal LN assessment. This is certainly an option based on NCCN guidelines. After surgery, there was an occult N1 node seen on the path. These patients are still at very high risk of...
Join for free or sign in to see the full answer